Clozapine N-oxide (BioDeep_00000017967)

   

human metabolite Endogenous blood metabolite


代谢物信息卡片


4-{6-chloro-2,9-diazatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,9,11,13-heptaen-10-yl}-1-methylpiperazin-1-ium-1-olate

化学式: C18H19ClN4O (342.1247314)
中文名称: 氯氮平N-氧化物
谱图信息: 最多检出来源 Homo sapiens(blood) 1.33%

分子结构信息

SMILES: C[N+]1(CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42)[O-]
InChI: InChI=1S/C18H19ClN4O/c1-23(24)10-8-22(9-11-23)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3

描述信息

Clozapine N-oxide is a metabolite of clozapine. Clozapine (sold as Clozaril, Gen-Clozapine in Canada, Azaleptin, Leponex, Fazaclo, Froidir; Denzapine, Zaponex in the UK; Klozapol in Poland, Clopine in Australia and New Zealand) is an atypical antipsychotic medication used in the treatment of schizophrenia, and is also used off-label in the treatment of bipolar disorder. Wyatt. R and Chew. (Wikipedia)
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants
Clozapine N-oxide is a major metabolite of Clozapine and a human muscarinic designer receptors (DREADDs) agonist. Clozapine N-oxide activates the DREADD receptor hM3Dq and hM4Di. Clozapine N-oxide can cross the blood-brain barrier[1][2][3][4]. Clozapine is a potent dopamine antagonist and also a potent and selective muscarinic M4 receptor (EC50=11 nM) agonist[5][6].

同义名列表

3 个代谢物同义名

4-{6-chloro-2,9-diazatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,9,11,13-heptaen-10-yl}-1-methylpiperazin-1-ium-1-olate; Clozapine N-oxide; Clozapine-N-oxide



数据库引用编号

7 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Csilla Lea Fazekas, Manon Bellardie, Bibiána Török, Eszter Sipos, Blanka Tóth, Mária Baranyi, Beáta Sperlágh, Mihály Dobos-Kovács, Elodie Chaillou, Dóra Zelena. Pharmacogenetic excitation of the median raphe region affects social and depressive-like behavior and core body temperature in male mice. Life sciences. 2021 Dec; 286(?):120037. doi: 10.1016/j.lfs.2021.120037. [PMID: 34637795]
  • Wei Guo, Xiayun Wan, Li Ma, Jiancheng Zhang, Kenji Hashimoto. Abnormalities in the composition of the gut microbiota in mice after repeated administration of DREADD ligands. Brain research bulletin. 2021 08; 173(?):66-73. doi: 10.1016/j.brainresbull.2021.05.012. [PMID: 34004259]
  • Ai-Xiao Chen, Jing-Jing Yan, Wen Zhang, Lei Wang, Zi-Xian Yu, Xiao-Jing Ding, Dan-Yang Wang, Min Zhang, Yan-Li Zhang, Nan Song, Zhuo-Lei Jiao, Chun Xu, Shu-Jia Zhu, Xiao-Hong Xu. Specific Hypothalamic Neurons Required for Sensing Conspecific Male Cues Relevant to Inter-male Aggression. Neuron. 2020 11; 108(4):763-774.e6. doi: 10.1016/j.neuron.2020.08.025. [PMID: 32961129]
  • Karam Mazin Kamil Gharab, Duygu Eryavuz Onmaz, Sedat Abusoglu, Memduha Aydin, Abdullah Sivrikaya, Oguzhan Tok, Gulsum Abusoglu, Ali Unlu. The relationship between serum clozapine concentrations and hematological parameters by a validated mass spectrometric method. Journal of pharmaceutical and biomedical analysis. 2020 Feb; 180(?):113056. doi: 10.1016/j.jpba.2019.113056. [PMID: 31887669]
  • Man-Yi Jing, Xiao Han, Tai-Yun Zhao, Zhi-Yuan Wang, Guan-Yi Lu, Ning Wu, Rui Song, Jin Li. Re-examining the role of ventral tegmental area dopaminergic neurons in motor activity and reinforcement by chemogenetic and optogenetic manipulation in mice. Metabolic brain disease. 2019 10; 34(5):1421-1430. doi: 10.1007/s11011-019-00442-z. [PMID: 31313126]
  • Elisabeth Kaiser, Qinghai Tian, Michael Wagner, Monika Barth, Wenying Xian, Laura Schröder, Sandra Ruppenthal, Lars Kaestner, Ulrich Boehm, Philipp Wartenberg, Huiyan Lu, Sara M McMillin, Derek B J Bone, Jürgen Wess, Peter Lipp. DREADD technology reveals major impact of Gq signalling on cardiac electrophysiology. Cardiovascular research. 2019 05; 115(6):1052-1066. doi: 10.1093/cvr/cvy251. [PMID: 30321287]
  • Daicia C Allen, Timothy L Carlson, Yan Xiong, Jian Jin, Kathleen A Grant, Verginia C Cuzon Carlson. A Comparative Study of the Pharmacokinetics of Clozapine N-Oxide and Clozapine N-Oxide Hydrochloride Salt in Rhesus Macaques. The Journal of pharmacology and experimental therapeutics. 2019 02; 368(2):199-207. doi: 10.1124/jpet.118.252031. [PMID: 30523062]
  • Sanya Aggarwal, Celion Tang, Kristen Sing, Hyun Wook Kim, Robert P Millar, Javier A Tello. Medial Amygdala Kiss1 Neurons Mediate Female Pheromone Stimulation of Luteinizing Hormone in Male Mice. Neuroendocrinology. 2019; 108(3):172-189. doi: 10.1159/000496106. [PMID: 30537700]
  • Matthew G Sangoi, Shawn M Lamothe, Jun Guo, Tonghua Yang, Wentao Li, Ellen G Avery, John T Fisher, Shetuan Zhang. β-Arrestin-Mediated Regulation of the Human Ether-a-go-go-Related Gene Potassium Channel. Molecular pharmacology. 2017 08; 92(2):162-174. doi: 10.1124/mol.116.108035. [PMID: 28495999]
  • Jessica Raper, Ryan D Morrison, J Scott Daniels, Leonard Howell, Jocelyne Bachevalier, Thomas Wichmann, Adriana Galvan. Metabolism and Distribution of Clozapine-N-oxide: Implications for Nonhuman Primate Chemogenetics. ACS chemical neuroscience. 2017 07; 8(7):1570-1576. doi: 10.1021/acschemneuro.7b00079. [PMID: 28324647]
  • Dmitry Akhmedov, Maria G Mendoza-Rodriguez, Kavitha Rajendran, Mario Rossi, Jürgen Wess, Rebecca Berdeaux. Gs-DREADD Knock-In Mice for Tissue-Specific, Temporal Stimulation of Cyclic AMP Signaling. Molecular and cellular biology. 2017 05; 37(9):. doi: 10.1128/mcb.00584-16. [PMID: 28167604]
  • Shannon H Romer, Kari Seedle, Sarah M Turner, Jie Li, Mark L Baccei, Steven A Crone. Accessory respiratory muscles enhance ventilation in ALS model mice and are activated by excitatory V2a neurons. Experimental neurology. 2017 Jan; 287(Pt 2):192-204. doi: 10.1016/j.expneurol.2016.05.033. [PMID: 27456268]
  • Duncan A A MacLaren, Richard W Browne, Jessica K Shaw, Sandhya Krishnan Radhakrishnan, Prachi Khare, Rodrigo A España, Stewart D Clark. Clozapine N-Oxide Administration Produces Behavioral Effects in Long-Evans Rats: Implications for Designing DREADD Experiments. eNeuro. 2016 Sep; 3(5):. doi: 10.1523/eneuro.0219-16.2016. [PMID: 27822508]
  • Wei Wang, Dan-Dan Tian, Zhang-Jin Zhang. In Vitro Effects of Concomitant Use of Herbal Preparations on Cytochrome P450s Involved in Clozapine Metabolism. Molecules (Basel, Switzerland). 2016 May; 21(5):. doi: 10.3390/molecules21050597. [PMID: 27164071]
  • Kenta Wakaizumi, Takashige Kondo, Yusuke Hamada, Michiko Narita, Rui Kawabe, Hiroki Narita, Moe Watanabe, Shigeki Kato, Emiko Senba, Kazuto Kobayashi, Naoko Kuzumaki, Akihiro Yamanaka, Hiroshi Morisaki, Minoru Narita. Involvement of mesolimbic dopaminergic network in neuropathic pain relief by treadmill exercise: A study for specific neural control with Gi-DREADD in mice. Molecular pain. 2016; 12(?):. doi: 10.1177/1744806916681567. [PMID: 27909152]
  • Vincent Pascoli, Jean Terrier, Agnès Hiver, Christian Lüscher. Sufficiency of Mesolimbic Dopamine Neuron Stimulation for the Progression to Addiction. Neuron. 2015 Dec; 88(5):1054-1066. doi: 10.1016/j.neuron.2015.10.017. [PMID: 26586182]
  • Peng Zhong, Xiaojie Liu, Zhen Zhang, Ying Hu, Sarah J Liu, Martha Lezama-Ruiz, Milan Joksimovic, Qing-song Liu. Cyclin-dependent kinase 5 in the ventral tegmental area regulates depression-related behaviors. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2014 Apr; 34(18):6352-66. doi: 10.1523/jneurosci.3673-13.2014. [PMID: 24790206]
  • Michael J Krashes, Bhavik P Shah, Joseph C Madara, David P Olson, David E Strochlic, Alastair S Garfield, Linh Vong, Hongjuan Pei, Mitsuko Watabe-Uchida, Naoshige Uchida, Stephen D Liberles, Bradford B Lowell. An excitatory paraventricular nucleus to AgRP neuron circuit that drives hunger. Nature. 2014 Mar; 507(7491):238-42. doi: 10.1038/nature12956. [PMID: 24487620]
  • Ling-ling Jia, Ze-yu Zhong, Feng Li, Zhao-li Ling, Yang Chen, Wei-man Zhao, Ying Li, Shu-wen Jiang, Ping Xu, Yang Yang, Meng-yue Hu, Li Liu, Xiao-dong Liu. Aggravation of clozapine-induced hepatotoxicity by glycyrrhetinic acid in rats. Journal of pharmacological sciences. 2014; 124(4):468-79. doi: 10.1254/jphs.13257fp. [PMID: 24739264]
  • Bianca A Silva, Camilla Mattucci, Piotr Krzywkowski, Emanuele Murana, Anna Illarionova, Valery Grinevich, Newton S Canteras, Davide Ragozzino, Cornelius T Gross. Independent hypothalamic circuits for social and predator fear. Nature neuroscience. 2013 Dec; 16(12):1731-3. doi: 10.1038/nn.3573. [PMID: 24212674]
  • Shalini Jain, Inigo Ruiz de Azua, Huiyan Lu, Morris F White, Jean-Marc Guettier, Jürgen Wess. Chronic activation of a designer G(q)-coupled receptor improves β cell function. The Journal of clinical investigation. 2013 Apr; 123(4):1750-62. doi: 10.1172/jci66432. [PMID: 23478411]
  • Anke Kaufmann, Anja Keim, Gerald Thiel. Regulation of immediate-early gene transcription following activation of Gα(q)-coupled designer receptors. Journal of cellular biochemistry. 2013 Mar; 114(3):681-96. doi: 10.1002/jcb.24410. [PMID: 23059951]
  • Ken-ichiro Nakajima, Jürgen Wess. Design and functional characterization of a novel, arrestin-biased designer G protein-coupled receptor. Molecular pharmacology. 2012 Oct; 82(4):575-82. doi: 10.1124/mol.112.080358. [PMID: 22821234]
  • Ariane Wohlfarth, Nicole Toepfner, Maren Hermanns-Clausen, Volker Auwärter. Sensitive quantification of clozapine and its main metabolites norclozapine and clozapine-N-oxide in serum and urine using LC-MS/MS after simple liquid-liquid extraction work-up. Analytical and bioanalytical chemistry. 2011 May; 400(3):737-46. doi: 10.1007/s00216-011-4831-8. [PMID: 21394453]
  • Jean-Marc Guettier, Dinesh Gautam, Marco Scarselli, Inigo Ruiz de Azua, Jian Hua Li, Erica Rosemond, Xiaochao Ma, Frank J Gonzalez, Blaine N Armbruster, Huiyan Lu, Bryan L Roth, Jürgen Wess. A chemical-genetic approach to study G protein regulation of beta cell function in vivo. Proceedings of the National Academy of Sciences of the United States of America. 2009 Nov; 106(45):19197-202. doi: 10.1073/pnas.0906593106. [PMID: 19858481]
  • Wei V Zhang, Iqbal Ramzan, Michael Murray. Impaired microsomal oxidation of the atypical antipsychotic agent clozapine in hepatic steatosis. The Journal of pharmacology and experimental therapeutics. 2007 Aug; 322(2):770-7. doi: 10.1124/jpet.107.124024. [PMID: 17522342]
  • Shih-Ku Lin, Sheng-Fen Su, Chun-Hung Pan. Higher plasma drug concentration in clozapine-treated schizophrenic patients with side effects of obsessive/compulsive symptoms. Therapeutic drug monitoring. 2006 Jun; 28(3):303-7. doi: 10.1097/01.ftd.0000211801.66569.80. [PMID: 16778711]
  • Karen E Mosier, Jiuxue Song, Gordon McKay, John W Hubbard, Jim Fang. Determination of clozapine, and its metabolites, N-desmethylclozapine and clozapine N-oxide in dog plasma using high-performance liquid chromatography. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2003 Jan; 783(2):377-82. doi: 10.1016/s1570-0232(02)00655-4. [PMID: 12482480]
  • Philip Heiser, Christiane Hausmann, Joachim Frey, Frank Geller, Ralf Becker, Wolfgang Wesemann, Jürgen Christian Krieg, Helmut Remschmidt, Helmut Vedder. Serotonergic effects of clozapine and its metabolites in hippocampal HT22 cells. Psychiatry research. 2002 Nov; 112(3):221-9. doi: 10.1016/s0165-1781(02)00239-1. [PMID: 12450631]
  • Pierre-Michel Llorca, Christophe Lancon, Béatrice Disdier, Jean Farisse, Christophe Sapin, Pascal Auquier. Effectiveness of clozapine in neuroleptic-resistant schizophrenia: clinical response and plasma concentrations. Journal of psychiatry & neuroscience : JPN. 2002 Jan; 27(1):30-7. doi: NULL. [PMID: 11836974]
  • K Raaska, V Raitasuo, P J Neuvonen. Effect of influenza vaccination on serum clozapine and its main metabolite concentrations in patients with schizophrenia. European journal of clinical pharmacology. 2001 Dec; 57(10):705-8. doi: 10.1007/s002280100375. [PMID: 11829199]
  • H Y Lane, M W Jann, Y C Chang, C C Chiu, M C Huang, S H Lee, W H Chang. Repeated ingestion of grapefruit juice does not alter clozapine's steady-state plasma levels, effectiveness, and tolerability. The Journal of clinical psychiatry. 2001 Oct; 62(10):812-7. doi: 10.4088/jcp.v62n1010. [PMID: 11816871]
  • M Aravagiri, S R Marder. Simultaneous determination of clozapine and its N-desmethyl and N-oxide metabolites in plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to plasma level monitoring in schizophrenic patients. Journal of pharmaceutical and biomedical analysis. 2001 Sep; 26(2):301-11. doi: 10.1016/s0731-7085(01)00410-1. [PMID: 11470207]
  • Y Y Liu, L J van Troostwijk, H J Guchelaar. Simultaneous determination of clozapine, norclozapine and clozapine-N-oxide in human plasma by high-performance liquid chromatography with ultraviolet detection. Biomedical chromatography : BMC. 2001 Jun; 15(4):280-6. doi: 10.1002/bmc.73. [PMID: 11438972]
  • C Guitton, J M Kinowski, M Abbar, P Chabrand, F Bressolle. Clozapine and metabolite concentrations during treatment of patients with chronic schizophrenia. Journal of clinical pharmacology. 1999 Jul; 39(7):721-8. doi: 10.1177/00912709922008245. [PMID: 10392327]
  • G Facciolà, A Avenoso, M G Scordo, A G Madia, A Ventimiglia, E Perucca, E Spina. Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders. Therapeutic drug monitoring. 1999 Jun; 21(3):341-5. doi: 10.1097/00007691-199906000-00017. [PMID: 10365650]
  • G Facciolà, A Avenoso, E Spina, E Perucca. Inducing effect of phenobarbital on clozapine metabolism in patients with chronic schizophrenia. Therapeutic drug monitoring. 1998 Dec; 20(6):628-30. doi: 10.1097/00007691-199812000-00008. [PMID: 9853978]
  • C Guitton, M Abbar, J M Kinowski, P Chabrand, F Bressolle. Multiple-dose pharmacokinetics of clozapine in patients with chronic schizophrenia. Journal of clinical psychopharmacology. 1998 Dec; 18(6):470-6. doi: 10.1097/00004714-199812000-00010. [PMID: 9864080]
  • G Schaber, I Stevens, H J Gaertner, K Dietz, U Breyer-Pfaff. Pharmacokinetics of clozapine and its metabolites in psychiatric patients: plasma protein binding and renal clearance. British journal of clinical pharmacology. 1998 Nov; 46(5):453-9. doi: 10.1046/j.1365-2125.1998.00822.x. [PMID: 9833598]
  • A Avenoso, G Facciolà, G M Campo, A Fazio, E Spina. Determination of clozapine, desmethylclozapine and clozapine N-oxide in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection. Journal of chromatography. B, Biomedical sciences and applications. 1998 Sep; 714(2):299-308. doi: 10.1016/s0378-4347(98)00202-3. [PMID: 9766870]
  • W H Chang, S K Lin, H Y Lane, F C Wei, W H Hu, Y W Lam, M W Jann. Reversible metabolism of clozapine and clozapine N-oxide in schizophrenic patients. Progress in neuro-psychopharmacology & biological psychiatry. 1998 Jul; 22(5):723-39. doi: 10.1016/s0278-5846(98)00035-9. [PMID: 9723115]
  • B Eiermann, G Engel, I Johansson, U M Zanger, L Bertilsson. The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine. British journal of clinical pharmacology. 1997 Nov; 44(5):439-46. doi: 10.1046/j.1365-2125.1997.t01-1-00605.x. [PMID: 9384460]
  • H Weigmann, J Bierbrauer, S Härtter, C Hiemke. Automated determination of clozapine and major metabolites in serum and urine. Therapeutic drug monitoring. 1997 Aug; 19(4):480-8. doi: 10.1097/00007691-199708000-00020. [PMID: 9263393]
  • C Guitton, J M Kinowski, R Aznar, F Bressolle. Determination of clozapine and its major metabolites in human plasma and red blood cells by high-performance liquid chromatography with ultraviolet absorbance detection. Journal of chromatography. B, Biomedical sciences and applications. 1997 Mar; 690(1-2):211-22. doi: 10.1016/s0378-4347(96)00362-3. [PMID: 9106046]
  • P Odou, B Frimat, B Fontaine, M Luyckx, C Brunet, H Robert, T Dine, B Gressier, M Cazin, J C Cazin. Determination of clozapine in serum by radioreceptor assay versus high-performance liquid chromatography: possible detection of hydroxy-metabolites. Journal of clinical pharmacy and therapeutics. 1996 Oct; 21(5):337-42. doi: 10.1111/j.1365-2710.1996.tb00028.x. [PMID: 9119916]
  • G Lin, G McKay, K K Midha. Characterization of metabolites of clozapine N-oxide in the rat by micro-column high performance liquid chromatography/mass spectrometry with electrospray interface. Journal of pharmaceutical and biomedical analysis. 1996 Aug; 14(11):1561-77. doi: 10.1016/0731-7085(96)01738-4. [PMID: 8877864]
  • J S Markowitz, K S Patrick. Thermal degradation of clozapine-N-oxide to clozapine during gas chromatographic analysis. Journal of chromatography. B, Biomedical applications. 1995 Jun; 668(1):171-4. doi: 10.1016/0378-4347(95)00060-v. [PMID: 7550974]
  • F Centorrino, R J Baldessarini, J G Flood, J C Kando, F R Frankenburg. Relation of leukocyte counts during clozapine treatment to serum concentrations of clozapine and metabolites. The American journal of psychiatry. 1995 Apr; 152(4):610-2. doi: 10.1176/ajp.152.4.610. [PMID: 7694912]
  • E O Fadiran, J Leslie, M Fossler, D Young. Determination of clozapine and its major metabolites in human serum and rat plasma by liquid chromatography using solid-phase extraction and ultraviolet detection. Journal of pharmaceutical and biomedical analysis. 1995 Feb; 13(2):185-90. doi: 10.1016/0731-7085(93)e0020-n. [PMID: 7766727]
  • G Lin, G McKay, J W Hubbard, K K Midha. Decomposition of clozapine N-oxide in the qualitative and quantitative analysis of clozapine and its metabolites. Journal of pharmaceutical sciences. 1994 Oct; 83(10):1412-7. doi: 10.1002/jps.2600831010. [PMID: 7884661]
  • D Bender, M Holschbach, G Stöcklin. Synthesis of n.c.a. carbon-11 labelled clozapine and its major metabolite clozapine-N-oxide and comparison of their biodistribution in mice. Nuclear medicine and biology. 1994 Oct; 21(7):921-5. doi: 10.1016/0969-8051(94)90080-9. [PMID: 9234345]
  • M W Jann, Y W Lam, W H Chang. Rapid formation of clozapine in guinea-pigs and man following clozapine-N-oxide administration. Archives internationales de pharmacodynamie et de therapie. 1994 Sep; 328(2):243-50. doi: NULL. [PMID: 7710309]
  • S A Volpicelli, F Centorrino, P R Puopolo, J Kando, F R Frankenburg, R J Baldessarini, J G Flood. Determination of clozapine, norclozapine, and clozapine-N-oxide in serum by liquid chromatography. Clinical chemistry. 1993 Aug; 39(8):1656-9. doi: 10.1093/clinchem/39.8.1656. [PMID: 8353952]
  • H Weigmann, C Hiemke. Determination of clozapine and its major metabolites in human serum using automated solid-phase extraction and subsequent isocratic high-performance liquid chromatography with ultraviolet detection. Journal of chromatography. 1992 Dec; 583(2):209-16. doi: 10.1016/0378-4347(92)80554-4. [PMID: 1478985]